Senti Biosciences Holdings annual operating expenses
2021
2022
2023
2024
2025
Senti Biosciences Holdings Operating Expenses Growth & History (SNTI)
Senti Biosciences Holdings's operating expenses was $68.8M for fiscal 2025.
View full Senti Biosciences Holdings company overviewSenti Biosciences Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $68.8M | $7.8M | +12.72% |
| 2024 | 2024-12-31 | $61.0M | −$34.2M | −35.94% |
| 2023 | 2023-12-31 | $95.3M | $28.9M | +43.57% |
| 2022 | 2022-12-31 | $66.4M | $23.2M | +53.61% |
| 2021 | 2021-12-31 | $43.2M | — | — |
Senti Biosciences Holdings quarterly operating expenses
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $14.5M | −$2.3M | −13.64% |
| Q1 2026 | 2026-03-31 | $4.6M | −$11.8M | −71.75% |
| Q4 2025 | 2025-12-31 | $18.7M | $2.5M | +15.41% |
| Q3 2025 | 2025-09-30 | $16.9M | $1.7M | +11.39% |
| Q2 2025 | 2025-06-30 | $16.8M | $3.4M | +25.77% |
| Q1 2025 | 2025-03-31 | $16.4M | $96,000 | +0.59% |
| Q4 2024 | 2024-12-31 | $16.2M | −$2.5M | −13.54% |
| Q3 2024 | 2024-09-30 | $15.2M | −$29.0M | −65.59% |
| Q2 2024 | 2024-06-30 | $13.4M | −$2.8M | −17.17% |
| Q1 2024 | 2024-03-31 | $16.3M | $51,000 | +0.31% |
| Q4 2023 | 2023-12-31 | $18.7M | $4.8M | +34.86% |
| Q3 2023 | 2023-09-30 | $44.2M | $27.7M | +167.74% |
| Q2 2023 | 2023-06-30 | $16.1M | −$7.0M | −30.28% |
| Q1 2023 | 2023-03-31 | $16.3M | $3.4M | +26.34% |
| Q4 2022 | 2022-12-31 | $13.9M | — | — |
| Q3 2022 | 2022-09-30 | $16.5M | $4.0M | +31.84% |
| Q2 2022 | 2022-06-30 | $23.1M | $13.3M | +136.28% |
| Q1 2022 | 2022-03-31 | $12.9M | — | — |
| Q3 2021 | 2021-09-30 | $12.5M | — | — |
| Q2 2021 | 2021-06-30 | $9.8M | — | — |
Senti Biosciences Holdings operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Senti Biosciences Holdings's operating expenses increased from $43.2M to $68.8M, a change of $25.6M. The latest reported quarter, Q2 2026, shows $14.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Senti Biosciences Holdings source filings ↗